Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathy

AIMS: Peripartum cardiomyopathy (PPCM) is a systolic left ventricular dysfunction developing in the peripartum phase in previously healthy women. Relaxin-2 is a pregnancy hormone with potential beneficial effects in heart failure patients. We evaluated Relaxin-2 as a potential diagnostic marker and/...

Descripción completa

Detalles Bibliográficos
Autores principales: Nonhoff, Justus, Ricke-Hoch, Melanie, Mueller, Mirco, Stapel, Britta, Pfeffer, Tobias, Kasten, Martina, Scherr, Michaela, von Kaisenberg, Constantin, Bauersachs, Johann, Haghikia, Arash, Hilfiker-Kleiner, Denise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412020/
https://www.ncbi.nlm.nih.gov/pubmed/28453725
http://dx.doi.org/10.1093/cvr/cvw245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412020/
https://www.ncbi.nlm.nih.gov/pubmed/28453725
http://dx.doi.org/10.1093/cvr/cvw245

Ejemplares similares